Over the last couple of years, the Triple-I Initiative has established itself as a showcase that's worth keeping an eye on.

Managing multiple Claude Code projects doesn't have to be chaotic. My iTerm2 setup dramatically reduces friction in my daily ...

As I write this, four astronauts are on their way around the moon for the first time in 50 years. A lot us have asked ...

Landmark, third-party research strengthens evidence of long-term impact beyond a single Girls on the Run season. CHARLOTTE, NC, UNITED STATES, March 25, 2026 ...

EDMONDS, Wash. — Syreh Sonko is studying nursing at Edmonds College through Washington state's Running Start, but the program that's saving her nearly $30,000 in college costs may soon look different.

Running is one of the best investments you can make in yourself as you get older—and it’s never too late to start (or start again). Our new program, How to Run Strong at 50+, is designed to help you ...

Notre Dame football has been recruiting the running back position as well as anyone over the last several years. Former running backs coach Delend McCullough did a magnificent job of attracting top ...

When students talk about the ability to take Running Start courses during the summer, they don’t talk about credits; they talk about opportunity. For one high school student, enrolling in a summer ...

Jason Chun is a CNET writer covering a range of topics in tech, home, wellness, finance and streaming services. He is passionate about language and technology, and has been an avid writer/reader of ...

TURKU, Finland, Feb. 10, 2026 /PRNewswire/ -- Vaadin, the leading provider of Java web application frameworks, today announced the general availability of Swing Modernization Toolkit, a solution that ...

Current school board member Rae Gallagher said she hopes to continue preserving protections and programs for students in her reelection run for the Frederick County Board of Education. She said she ...

Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.